Kezar Life Sciences Inc (KZR)
0.7633
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.7633
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Cash and Short Term Investments (Quarterly): 179.80M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 179.80M |
| December 31, 2023 | 201.37M |
| September 30, 2023 | 218.20M |
| June 30, 2023 | 236.59M |
| March 31, 2023 | 257.67M |
| December 31, 2022 | 276.56M |
| September 30, 2022 | 290.38M |
| June 30, 2022 | 306.84M |
| March 31, 2022 | 242.61M |
| December 31, 2021 | 208.36M |
| September 30, 2021 | 120.76M |
| June 30, 2021 | 128.98M |
| March 31, 2021 | 142.31M |
| Date | Value |
|---|---|
| December 31, 2020 | 140.45M |
| September 30, 2020 | 149.95M |
| June 30, 2020 | 157.47M |
| March 31, 2020 | 123.35M |
| December 31, 2019 | 78.21M |
| September 30, 2019 | 85.24M |
| June 30, 2019 | 93.42M |
| March 31, 2019 | 101.13M |
| December 31, 2018 | 107.43M |
| September 30, 2018 | 112.76M |
| June 30, 2018 | 118.38M |
| March 31, 2018 | 47.08M |
| December 31, 2017 | 51.03M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
78.21M
Minimum
Dec 2019
306.84M
Maximum
Jun 2022
181.93M
Average
168.63M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Accuray Inc | 60.45M |
| Tonix Pharmaceuticals Holding Corp | 7.049M |
| Acumen Pharmaceuticals Inc | 252.51M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |